Search Platform

All Cases PTAB Litigations UPC Oppositions

Gilead Sciences Inc. v. Watson Laboratories Inc.

1:15-cv-00289

Overview

Case Number 1:15-cv-00289

Filing Date 2015-04-01

Status Terminated

Termination Date 2015-04-27

Court District Court, D. Delaware (ded)

Presiding Judge Sue L. Robinson

Nature of Suit 830 Patent

Jurisdiction Type Federal Question

Cause of Action 35:271 Patent Infringement

Jury Demand None

Parties

Defendant

Actavis plc

Represented By

0 Attorneys Listed

No attorneys available

Actavis Inc.

Represented By

0 Attorneys Listed

No attorneys available

Watson Laboratories Inc.

Represented By

0 Attorneys Listed

No attorneys available

Plaintiff

Royalty Pharma Collection Trust

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300

Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300

Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Gilead Sciences Inc.

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300

Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300

Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Sue L. Robinson

Patents Involved

1 Patent

There is a single patent involved in this case.

Application Number	Patent Number	External Links
-	USRE42462	Espacenet Google Patents

Docket Entries

COMPLAINT FOR PATENT INFRINGEMENT - filed against Actavis Inc., Actavis plc, Watson Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1701120.) - filed by Gilead Sciences Inc., Royalty Pharma Collection Trust. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(etg, ) (Entered: 04/02/2015)

2015-04-01

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (etg, ) (Entered: 04/02/2015)

2015-04-01

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/23/15. Date of Expiration of Patent: 07/29/18.Thirty Month Stay Deadline: 8/23/2017. (etg, ) (Entered: 04/02/2015)

2015-04-01

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE42,462. (etg, ) (Entered: 04/02/2015)

2015-04-01

1

View